Zydus Cadila has received emergency use approval from the Indian regulator for the use of its anti-viral drug 'Virafin'. Pharma giant Zydus says 91.15 per cent of adult patients treated with Virafin tested negative using RT-PCR in seven days. Virafin helps body cope with Interferon Alpha deficiency In its Phase III clinical trials, researchers found that a higher proportion of …
Gujarat-based drug manufacturer Zydus Cadila today said it has received approval from the Drugs Controller General of India to conduct Phase 3 clinical trials on its re-purposed drug that it hopes to use for Covid-19 treatment. The drug, Pegylated Interferon alpha-2b, 'PegiHepTM', is an approved drug that been in use since 2001 and is now being re-purposed to treat Covid-19 …
